Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma - Quaterly Results

Date: 14-11-2023
The total revenue hovered 165.02% to Rs. 9305.00 millions for the September 2023 quarter as against Rs. 3511.00 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 855.44% to Rs. 3602.00  millions from Rs. 377.00 millions in the previous quarter.The company reported a good operating profit of 4670.00 millions compared to 863.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 9305.00 3511.00 165.02 19788.00 11568.00 71.06 23510.00 17678.00 32.99
Other Income 247.00 162.00 52.47 393.00 494.00 -20.45 855.00 946.00 -9.62
PBIDT 4670.00 863.00 441.14 9853.00 4989.00 97.49 9302.00 3076.00 202.41
Interest 30.00 17.00 76.47 62.00 44.00 40.91 86.00 133.00 -35.34
PBDT 4640.00 846.00 448.46 9791.00 4945.00 98.00 9216.00 2943.00 213.15
Depreciation 400.00 383.00 4.44 799.00 752.00 6.25 1509.00 1384.00 9.03
PBT 4240.00 463.00 815.77 8992.00 4193.00 114.45 7707.00 1559.00 394.36
TAX 638.00 86.00 641.86 1337.00 736.00 81.66 1336.00 168.00 695.24
Deferred Tax -115.00 -6.00 1816.67 -254.00 -16.00 1487.50 5.00 -157.00 -103.18
PAT 3602.00 377.00 855.44 7655.00 3457.00 121.43 6371.00 1391.00 358.02
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 365.00 365.00 0.00
PBIDTM(%) 50.19 24.58 104.18 49.79 43.13 15.45 39.57 17.40 127.39